-
CDMO Great Bay Bio Founded
contractpharma
June 19, 2019
To build platform for CMC technology and pre-clinical R&D; names Michael Chan as CEO.
-
China puts focus on tackling biomedical problems
biospectrumasia
April 29, 2019
Collaborating with CMC and China National Center for Biotechnology Development (CNCBD), ICGEB decided to set up the world’s first ICGEB regional research center (ICGEB-RRC) at CMC.
-
Numab & Intarcia Enter License Agreement
contractpharma
March 07, 2019
Intarcia Therapeutics Inc. has executed its option to in-license ND016, being developed for the treatment of autoimmune disorders
-
WuXi STA, Ark Biosciences sign CMC development agreement
biospectrumasia
March 06, 2019
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Ark Biosciences, a global biotech company focusing on innovative drug discovery and development, especially in the area of viral infection and respiratory disease, have announced
-
DIA – CMC Workshop
pharmafile
May 15, 2018
This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena.
-
Just China secures closing of Series B financing
biospectrumasia
August 11, 2017
Globally, Just China has already established clinical development and CMC capabilities with a strong pipeline consisting of both bionovel and biosimilar products.
-
CMC Expands to Offer cGMP Processing
contractpharma
March 30, 2017
Custom Milling & Consulting (CMC) has constructed a brand new state-of-the-art class 100,000/ISO 8 cGMP clean room.